Pfizer-BioNTech COVID-19 vaccine 95% effective in final trial

Pfizer and BioNTec are preparing to submit their vaccine to US regulators for approval for emergency use. The two pharma firms claim the product is effective in 95% of the cases with no major safety concerns.